Skip to main content

Advertisement

SpringerLink
Log in

Primary splenic histiocytic sarcoma successfully treated with splenectomy: a case report and literature review

  • Case report
  • Published:
International Cancer Conference Journal Aims and scope Submit manuscript

Abstract

A 61-year-old woman was referred to our hospital with refractory thrombocytopenia and splenomegaly. She was diagnosed with immune thrombocytopenia 3 years prior to admission and received steroid therapy. However, her platelet count started decreasing six months prior to admission. A diagnostic and therapeutic splenectomy was performed, which led to the diagnosis of histiocytic sarcoma. The patient’s platelet count recovered promptly after splenectomy, and she was in complete remission for over a year.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ et al (2014) Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology 65(2):261–272

    Article  Google Scholar 

  2. Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B et al (2012) High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 120(13):2700–2703

    Article  CAS  Google Scholar 

  3. Liu Q, Tomaszewicz K, Hutchinson L, Hornick JL, Woda B, Yu H (2016) Somatic mutations in histiocytic sarcoma identified by next generation sequencing. Virchows Arch 469(2):233

    Article  CAS  Google Scholar 

  4. Voruz S, Cairoli A, Naveiras O, Leval LD, Missiaglia E, Homicsko K et al (2018) Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma. Haematologica 103(1):e39–e41

    Article  Google Scholar 

  5. Gounder MM, Solit BD, Tap DW (2018) Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation. N Engl J Med. 378(20):1945–1947

    Article  Google Scholar 

  6. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235

    Article  CAS  Google Scholar 

  7. Gisselbrecht C, Glass B, Mounier N, Singh Gill D, Linch DC, Trneny M et al (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 28(27):4184

    Article  Google Scholar 

  8. Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS (2005) Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 18:693–704

    Article  Google Scholar 

  9. Hornick JL, Jaffe ES, Fletcher CD (2004) Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 28:1133–1144

    Article  Google Scholar 

  10. Franchino C, Reich C, Distenfeld A, Ubriaco A, Knowles DM (1988) A clinicopathologically distinctive primary splenic histiocytic neoplasm. Demonstration of its histiocyte derivation by immunophenotypic and molecular genetic analysis. Am J Surg Pathol. 12:398–404

    Article  CAS  Google Scholar 

  11. Kimura H, Nasu K, Sakai C, Shiga Y, Miyamoto E, Shintaku M, Wakatsuki S, Tominaga K, Abe M, Maruyama Y (1998) Histiocytic sarcoma of the spleen associated with hypoalbuminemia, hypo gamma-globulinemia and thrombocytopenia as a possibly unique clinical entity–report of three cases. Leuk Lymphoma 31:217–224

    Article  CAS  Google Scholar 

  12. Audouin J, Vercelli-Retta J, Le Tourneau A, Adida C, Camilleri-Broët S, Molina T, Diebold J (2003) Primary histiocytic sarcoma of the spleen associated with erythrophagocytic histiocytosis. Pathol Res Pract 199:107–112

    Article  Google Scholar 

  13. Paik JH, Jeon YK, Park SS, Min HS, Kim YA, Kim JE et al (2005) Histiocytic sarcoma of the spleen - A case report and review of the literature. Korean J Pathol 39:356–359

    Google Scholar 

  14. Oka K, Nakamine H, Maeda K, Yamakawa M, Imai H, Tada K, Ito M, Watanabe Y, Suzuki H, Iwasa M, Tanaka I (2008) Primary histiocytic sarcoma of the spleen associated with hemophagocytosis. Int J Hematol 87:405–409

    Article  Google Scholar 

  15. Kobayashi S, Kimura F, Hama Y, Ogura K, Torikai H, Kobayashi A, Ikeda T, Sato K, Aida S, Kosuda S, Motoyoshi K (2008) Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features. Int J Hematol 87:83–87

    Article  Google Scholar 

  16. Yamada S, Tasaki T, Satoh N, Nabeshima A, Kitada S, Noguchi H, Yamada K, Takeshita M, Sasaguri Y (2012) Primary splenic histiocytic sarcoma complicated with prolonged idiopathic thrombocytopenia and secondary bone marrow involvement: a unique surgical case presenting with splenomegaly but non-nodular lesions. Diagn Pathol 7:143

    Article  Google Scholar 

  17. Yamamoto S, Tsukamoto T, Kanazawa A, Shimizu S, Morimura K, Toyokawa T, Xiang Z, Sakurai K, Fukuoka T, Yoshida K, Takii M, Inoue K (2013) Laparoscopic splenectomy for histiocytic sarcoma of the spleen. World J Gastrointest Surg 5:129–134

    Article  Google Scholar 

  18. Huang K, Columbie AF, Allan RW, Misra S (2020) Thrombocytopenia with multiple splenic lesions - histiocytic sarcoma of the spleen without splenomegaly: A case report. World J Clin Oncol 11(3):162–168

    Article  Google Scholar 

  19. Egan C, Nicolae A, Lack J, Chung HJ, Skarshaug S, Pham TA et al (2020) Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica 105(4):951–960

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Editage (www.editage.com) for English language editing.

Author information

Authors and Affiliations

  1. Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Koutoubashi, Sumida-ku, Tokyo, 130-8575, Japan

    Masayuki Kobayashi, Ken Suzaki & Nobuharu Kosugi

  2. Department of Internal Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan

    Keita Sugawara

Authors
  1. Masayuki Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keita Sugawara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken Suzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nobuharu Kosugi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masayuki Kobayashi.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobayashi, M., Sugawara, K., Suzaki, K. et al. Primary splenic histiocytic sarcoma successfully treated with splenectomy: a case report and literature review. Int Canc Conf J 11, 201–204 (2022). https://doi.org/10.1007/s13691-022-00548-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13691-022-00548-9

Keywords

Search

Navigation